NCT01229540

Brief Summary

Retinal neovascularization of diabetic retinopathy might be associated with genetic risk factors and environmental risk factors.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 26, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 27, 2010

Completed
Last Updated

October 27, 2010

Status Verified

September 1, 2008

First QC Date

October 26, 2010

Last Update Submit

October 26, 2010

Conditions

The Mechanism of Retinal Neovascularization of DiabeticRetinopathy.

Study Arms (1)

Lifestyle counseling

NO INTERVENTION
Genetic: genetic analyzer

Interventions

genetic analyzerGENETIC
Lifestyle counseling

Eligibility Criteria

Age45 Years - 74 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • T2DM was diagnosed according to the World Health Organization Expert Consultation Report 1999 and consisted of one of the following: fasting blood glucose (FBG) ≥7.0 mmol/L (≥126 mg/dL), blood glucose ≥11.1 mmol/L (≥200 mg/dL) 2 hours after an oral glucose tolerance test (OGTT); or a random blood glucose ≥11.1 mmol/L (≥200 mg/dL).
  • DR was clinically graded in accordance with the International Clinical Diabetic Retinopathy guidelines based on fundus fluorescence angiography.
  • All participants with PDR underwent a comprehensive dilated fundus examination to detect DR by indirect ophthalmoscopy and were diagnosed by fundus fluorescence angiography.

You may not qualify if:

  • Patients were excluded if they had acute complications of diabetes mellitus, type 1 diabetes mellitus, other types of diabetes, serious cardiovascular, hepatic, nephritic or other complications, other serious primary diseases or mental illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tianjin Eye Hospital, Clinical college of Ophthalmology ,Tianjin Medical Univercity

Tianjin, Tianjin Municipality, 300020, China

Location

MeSH Terms

Conditions

Retinal Diseases

Condition Hierarchy (Ancestors)

Eye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 26, 2010

First Posted

October 27, 2010

Last Updated

October 27, 2010

Record last verified: 2008-09

Locations

CN(1)